These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4870019)

  • 21. [Chemotherapeutic study of ampicillin in experimental infections].
    Petrova MA; Berezina EK; Chavdarova VB
    Antibiotiki; 1968 Sep; 13(9):815-20. PubMed ID: 4884475
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activity of di-N-hydroxyquinoxaline and depot-sulfanilamide derivatives in experimental NAG infection].
    Avtsyn AP; Pershin GN; Trager RS; Shakhlamov VA; Padeĭskaia EN
    Biull Eksp Biol Med; 1982 May; 93(5):76-8. PubMed ID: 7093514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [SULFAPYRIDAZINE IN PNEUMOCOCCAL MENINGITIS IN RABBITS].
    ISAMUKHAMEDOV I; PADEISKAIA EN; POLUKHINA LM; PERSHIN GN
    Farmakol Toksikol; 1964; 27():722-9. PubMed ID: 14321303
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of generalized forms of meningococcal infection with sulfalene meglumine].
    Vengerov IuIa; Lazukina LN; Kremenchugskaia IuA; Kutsemilova AP; Timina VP
    Ter Arkh; 1981; 53(4):108-11. PubMed ID: 7256626
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prolonged-action sulfanilamides].
    Astaf'ev VA
    Med Sestra; 1974 Jun; 33(6):37-8. PubMed ID: 4499530
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemotherapeutic action of quinozaline derivatives and N-oxides of quinoxaline in acute bacterial infections].
    Padeĭskaia EN; Elina AS; Pershin GN; Tsyrul'nikova LG; Belozerova KA
    Farmakol Toksikol; 1967; 30(5):617-26. PubMed ID: 4877416
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
    Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of coccidosis in rabbits].
    Dürr U; Schrecke W
    Dtsch Tierarztl Wochenschr (1946); 1970 Sep; 77(17):435-41. PubMed ID: 4916595
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapeutic activity of the combination of trimethoprim and sulphamethoxazole in infections of mice.
    Böhni E
    Postgrad Med J; 1969 Nov; 45():Suppl:18-21. PubMed ID: 4902845
    [No Abstract]   [Full Text] [Related]  

  • 30. Warning against prolonged-action sulfonamides.
    Med Lett Drugs Ther; 1966 Feb; 8(4):13-4. PubMed ID: 5907884
    [No Abstract]   [Full Text] [Related]  

  • 31. [Concentration of the prolonged action of sulfanilamides--sulfamethoxypyrazine (kelfizin) and sulfapyridazine in the blood and organs of albino mice].
    Polukhina LM; Padeĭskaia EN; Pershin GN
    Farmakol Toksikol; 1967; 30(4):470-3. PubMed ID: 5598904
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of chronic prostatitis with the preparation sulfalene].
    Minkov N; Tsvetkov D; Banchev A
    Akush Ginekol (Sofiia); 1984; 23(6):525-9. PubMed ID: 6532233
    [No Abstract]   [Full Text] [Related]  

  • 33. [Septicemias observed in a hospital department of general medicine].
    Portos JL; Christoforov B; Guerre J; Nevot P; Kazmierczak A; Péquignot H; Schaeffer A
    Ann Med Interne (Paris); 1971 Dec; 122(12):1255-61. PubMed ID: 4948805
    [No Abstract]   [Full Text] [Related]  

  • 34. Ampicillin.
    Med Lett Drugs Ther; 1967 Oct; 9(20):78-80. PubMed ID: 6059495
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.
    Brötz-Oesterhelt H; Beyer D; Kroll HP; Endermann R; Ladel C; Schroeder W; Hinzen B; Raddatz S; Paulsen H; Henninger K; Bandow JE; Sahl HG; Labischinski H
    Nat Med; 2005 Oct; 11(10):1082-7. PubMed ID: 16200071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosage regimen calculation of chemotherapeutic agents. IV. 5-sulfanilamido-1-ethyl-pyrazole.
    Krüger-Thiemer E; Roesch E; Rohmer M; Wempe E
    Chemotherapy; 1967; 12(6):321-37. PubMed ID: 4872781
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sulfanilamide preparations and anti-paratyphoid immunity in calves].
    Isaev VI
    Veterinariia; 1971 Apr; 4():39-40. PubMed ID: 5003838
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sulfanilamides of prolonged action--results and perspectives of their use in complex antibacterial therapy].
    Govorovich EA; Marshak AM
    Sov Med; 1967 Aug; 30(8):9-15. PubMed ID: 5610604
    [No Abstract]   [Full Text] [Related]  

  • 39. [Quantitative study of microdistribution of labelled sulfanilamides in tissues (on the eye as an example)].
    Gurtovoĭ GK
    Farmakol Toksikol; 1968; 31(5):579-81. PubMed ID: 5707730
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ways to increase the efficacy of antibiotics].
    Baskanchiladze GSh; Gamaleia LA
    Antibiotiki; 1968 Feb; 13(2):147-9. PubMed ID: 4875638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.